Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-99 Cr₹-99 Cr₹-85 Cr₹-100 Cr₹31 Cr

What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH is ₹-99 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-99 Cr
Mar2024₹-99 Cr
Mar2023₹-85 Cr
Mar2022₹-100 Cr
Mar2021₹31 Cr

How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-99 Cr
Negative
Mar2024 ₹-99 Cr
Negative
Mar2023 ₹-85 Cr
Negative
Mar2022 ₹-100 Cr
Negative
Mar2021 ₹31 Cr -

Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,259.1 Cr 21% -2.2% -44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 5% -0.1% 3.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

21%

-2.2%

-44.3%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses